TrialBMC cancer2020

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial.

S Sanghera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.